Tether Freezes 22 Wallets Across Ethereum and Tron

TheCryptoTimes2025-10-17 tarihinde yayınlandı2025-10-17 tarihinde güncellendi

Tether, the company behind the popular stablecoin USDT, has frozen $13.4 million worth of USDT spread across 22 wallets on the Ethereum and Tron networks. 

Blockchain tracking firm MistTrack reported that the largest share of the frozen funds, $10.3 million, was held in a single Ethereum address ‘0xecbd8…’. Another wallet ‘TYzDebk…’ on Tron contained USDT worth approximately $1.4 million.

The company has carried out similar actions throughout the year. In June, it froze more than $12.3 million, and in April 2025, around 28.67 million USDT was frozen across 13 wallets. 

In March, Tether froze $28 million in USDT on the Russian crypto exchange Garantex, though blockchain analysis firm Global Ledger noted that the exchange still held $15 million in active funds.

In a September 15 statement, Tether said it has frozen over $3.2 billion in USDT connected to criminal activity, working with more than 290 law enforcement agencies in 59 countries. Over the past year, the company has blocked around 3,660 wallets.

Why the wallets are frozen

Tether usually freezes wallets when requested by authorities like the U.S. Department of Justice (DOJ), the Federal Bureau of Investigation (FBI), or other international agencies. 

Wallets linked to fraud, terrorism, sanctioned entities, or illegal markets may be blocked to stop the movement of funds. The company also keeps an eye on blockchain activity to follow anti-money-laundering and sanctions rules.

Not everyone agrees with Tether’s approach. Recently, Texas-based Riverstone Consulting filed a lawsuit, claiming the company wrongly froze $44.7 million in April, which affected their investments. Riverstone says Tether skipped formal international procedures, including the Bulgarian International Judicial Assistance Treaty, which requires requests to go through official channels.

Also Read: Tether Donates $250K to OpenSats for Bitcoin Ecosystem Growth


Mobile Only ImageMobile Only Image

Trend Kriptolar

İlgili Okumalar

JPMorgan Research Report Analysis: Moderna's INT Trial Meets Endpoints, but Market Already Priced In

On August 19, J.P. Morgan (JPM) published a research report analyzing Moderna's recent Phase III trial success for its Individualized Neoantigen Therapy (INT), developed in partnership with Merck, in adjuvant melanoma. The trial met its primary endpoint of significantly improved recurrence-free survival and the key secondary endpoint of distant metastasis-free survival. While JPM acknowledged the strong clinical value of these results, particularly the prevention of distant metastasis, the bank stated that this success was widely anticipated, with an 85% prior probability of success, and is already reflected in Moderna's current market valuation. Following the announcement, Moderna's stock rose in pre-market trading. However, JPM maintained its Underweight rating and $40 price target, implying approximately 36% downside from the current price of ~$63. The core rationale is that the success in adjuvant melanoma, a relatively small market in immuno-oncology, is fully priced in. Moderna's future valuation hinges entirely on INT's ability to demonstrate similar efficacy across broader cancer indications. JPM's valuation model incorporates only a modest risk-adjusted value (~$3/share) for the melanoma approval. Approximately $15/share of its target price is attributed to INT's potential in other cancer types. The report identifies upcoming data readouts in non-melanoma cancers (e.g., lung, head & neck, renal) as the critical variable that will determine the platform's ultimate value. Upside risks include better-than-expected data in these new indications, while downside risks involve clinical failures, regulatory delays, or commercial underperformance. In conclusion, JPM views the pre-market stock move as driven by short covering and trading sentiment rather than a fundamental re-rating. The bank remains bearish, arguing that Moderna must now prove INT's efficacy as a platform technology beyond melanoma to justify its current market cap.

marsbit42 dk önce

JPMorgan Research Report Analysis: Moderna's INT Trial Meets Endpoints, but Market Already Priced In

marsbit42 dk önce

Treasury Department Directly Intervenes to Suppress Long-Term Interest Rates

The article discusses the U.S. Treasury's recent direct intervention to suppress long-term bond yields through buyback operations. While distinct from traditional Yield Curve Control (YCC), this move is interpreted as direct government intervention in its own financing costs. The author emphasizes the short-term tactical nature of this action and contrasts it with the Federal Reserve's upcoming, potentially divergent, policy stance at Jackson Hole. The core issue is framed as a long-term U.S. strategic dilemma: managing high deficit levels. The analysis argues that deficit reduction cannot realistically come from spending cuts or traditional industries, but must rely on achieving higher economic growth driven by technological breakthroughs. Current monetary tightening, while possibly curbing yields and inflation in the short term, is seen as potentially counterproductive to this necessary long-term investment in technology and supply chain resilience. The piece draws historical parallels, placing the current intervention between the 2000-2002 Treasury buybacks (for liquidity) and larger-scale Fed-led "Operation Twist" maneuvers. The effectiveness of the Treasury's action is deemed limited without Federal Reserve cooperation, which would signify a more significant policy shift. Ultimately, the author views such technical, bureaucratic interventions as treating symptoms rather than the underlying disease of the U.S. economy's structural challenges and "K-shaped" divergence. The conclusion suggests that sustained yield suppression by the Fed, combined with specific geopolitical outcomes, could serve as a catalyst for a more profound discussion on broader U.S. and dollar trajectory.

marsbit42 dk önce

Treasury Department Directly Intervenes to Suppress Long-Term Interest Rates

marsbit42 dk önce

İşlemler

Spot

Popüler Makaleler

TRX Nasıl Satın Alınır

HTX.com’a hoş geldiniz! TRON (TRX) satın alma işlemlerini basit ve kullanışlı bir hâle getirdik. Adım adım açıkladığımız rehberimizi takip ederek kripto yolculuğunuza başlayın. 1. Adım: HTX Hesabınızı OluşturunHTX'te ücretsiz bir hesap açmak için e-posta adresinizi veya telefon numaranızı kullanın. Sorunsuzca kaydolun ve tüm özelliklerin kilidini açın. Hesabımı Aç2. Adım: Kripto Satın Al Bölümüne Gidin ve Ödeme Yönteminizi SeçinKredi/Banka Kartı: Visa veya Mastercard'ınızı kullanarak anında TRON (TRX) satın alın.Bakiye: Sorunsuz bir şekilde işlem yapmak için HTX hesap bakiyenizdeki fonları kullanın.Üçüncü Taraflar: Kullanımı kolaylaştırmak için Google Pay ve Apple Pay gibi popüler ödeme yöntemlerini ekledik.P2P: HTX'teki diğer kullanıcılarla doğrudan işlem yapın.Borsa Dışı (OTC): Yatırımcılar için kişiye özel hizmetler ve rekabetçi döviz kurları sunuyoruz.3. Adım: TRON (TRX) Varlıklarınızı SaklayınTRON (TRX) satın aldıktan sonra HTX hesabınızda saklayın. Alternatif olarak, blok zinciri transferi yoluyla başka bir yere gönderebilir veya diğer kripto para birimlerini takas etmek için kullanabilirsiniz.4. Adım: TRON (TRX) Varlıklarınızla İşlem YapınHTX'in spot piyasasında TRON (TRX) ile kolayca işlemler yapın.Hesabınıza erişin, işlem çiftinizi seçin, işlemlerinizi gerçekleştirin ve gerçek zamanlı olarak izleyin. Hem yeni başlayanlar hem de deneyimli yatırımcılar için kullanıcı dostu bir deneyim sunuyoruz.

1.8k Toplam GörüntülenmeYayınlanma 2024.12.10Güncellenme 2026.06.02

TRX Nasıl Satın Alınır

Tartışmalar

HTX Topluluğuna hoş geldiniz. Burada, en son platform gelişmeleri hakkında bilgi sahibi olabilir ve profesyonel piyasa görüşlerine erişebilirsiniz. Kullanıcıların TRX (TRX) fiyatı hakkındaki görüşleri aşağıda sunulmaktadır.

活动图片